Skip to content

Walking Training Improves Thyroid and Cardiometabolic Markers in Postmenopausal Obesity

Moderate Intensity Intermittent Walking Training (MIWT) Improves Thyroid Function and Cardiometabolic Risk Factors in Obese Postmenopausal Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06793345
Enrollment
36
Registered
2025-01-27
Start date
2024-09-23
Completion date
2024-12-22
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiometabolic Risk Factors, Thyroid Hormones

Keywords

Thyroid hormones, Lipid profile, Obesity, Blood pressure, Moderate intensity intermittent walking training, Body composition

Brief summary

The goal of this clinical trial is to investigate the impact of a 10-week MIWT program on thyroid hormone levels and key cardiometabolic markers in obese postmenopausal women. The main question it aims to answer is: Does MIWT enhance thyroid function and reduce cardiometabolic risk factors in this population? Researchers will compare MIWT (designed to MIWT group) to non-training intervention (designed to control group) to see if the training program works to improve thyroid function and cardiometabolic risk factors. Participants in MIWT group will: perform a 10-week MIWT program, four sessions per week (5 repetitions of 6-min-walking-test (6MWT) at 60-80% of 6MWTdistance measured at baseline, interspersed by 6-min of active recovery between repetitions). Participants in control group will : not perform any physical training and maintain their usual daily activities.

Detailed description

This study aimed to investigate the impact of a 10-week MIWT program on thyroid hormone levels and key cardiometabolic markers in obese postmenopausal women. Thirty-six obese postmenopausal women (BMI≥30 kg.m-2, aged 50-60 yrs.) were randomized to either a moderate-intensity intermittent walking training (MIWT) group (n=18) or control group (CG, n=18). Participants performed a 10-week MIWT program, four sessions per week (5 repetitions of 6-min-walking-test (6MWT) at 60-80% of 6MWTdistance measured at baseline, interspersed by 6-min of active recovery between repetitions). Body composition, thyroid hormones (thyroid stimulating hormone (TSH) and thyroxine free (FT4)), lipid profile (triglycerides (TRG), total cholesterol(TC), high-density lipoprotein cholesterol(HDLC) and low-density lipoprotein cholesterol(LDLC)), blood pressure (systolic and diastolic blood pressure) and aerobic fitness (6MWT) were determined before and after the MIWT.

Interventions

OTHERModerate intensity intermittent walking training

The intensity of the training is 60 to 80% of 6MWTdistance.

Sponsors

Wissal Abassi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Body mass index≥ 30 kg.m-2. * Age between 50 and 60. * Amenorrhea for \>12 months. * Stable eating habits.

Exclusion criteria

* Chronic diseases. * Medical contraindications to physical activity. * Hormone replacement therapy.

Design outcomes

Primary

MeasureTime frameDescription
Thyroid hormonesAt baseline and after ten weeks of MIWT.Serum thyroid hormone concentrations are measured from a blood sample (5 ml) obtained from a prominent superficial vein in the antecubital region.
Body compositionAt baseline and after ten weeks of MIWT.Body composition was assessed using an electronic scale (Tanita BC-533, Tokyo, Japan),
Lipid profileAt baseline and after ten weeks of MIWT.Measured by blood samples (5ml) from a prominent superficial vein in the antecubital region.

Secondary

MeasureTime frameDescription
Systolic and diastolic blood pressureAt baseline and after ten weeks of MIWT.Systolic and diastolic blood pressure measurements were conducted using an automatic blood pressure monitor (Omron BP652, Omron Healthcare Inc., Vernon Hills, IL, USA).
Perceived exertion ratingAt baseline and after ten weeks of MIWT.Perceived exertion rating (RPE) was assessed with the extensively validated RPE, a 15-point scale ranging from 6 (no exertion at all) to 20 (maximal exertion).
Heart rateAt baseline and after ten weeks of MIWTHeart rate was recorded after 10 minutes of relaxation in a seated position using an automatic blood pressure monitor (Omron BP652, Omron Healthcare Inc., Vernon Hills, IL, USA).
6 min walking test distanceAt baseline and after ten weeks of MIWTIt was recorded using the 6 min walking test.

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026